A new treatment is effective for advanced HER2-low breast cancer
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
News about Breast cancer
An Hospital Clínic-IDIBAPS research project receives a CRIS Foundation grant
Aleix Prat is leading the research, which focuses on discovering new ways of diagnosing hormone receptor-positive breast cancer, as well as new thera1
Developed the first genomic test for personalized HER2+ breast cancer treatments
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1
A study explains how chemotherapy works in young women with low-risk hormone-sensitive breast cancer
Researchers from Hospital Clínic-IDIBAPS have shown for the first time that the benefit of chemotherapy in premenopausal patients with low-risk hormo1
A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of1
Spin-off Reveal Genomics born to develop innovative diagnostic tests in oncology
Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
A new biological treatment could replace chemotherapy in patients with aggressive breast cancer
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1